Sept 29 (Reuters) – European shares inched up on Monday as healthcare and technology shares rose, while investors focused on a possible U.S. government shutdown that could delay the release of key economic data.
The pan-European STOXX 600 (.STOXX), opens new tab rose 0.2% to 555.8 points by 0711 GMT, coming off a flat finish the previous week.
Sign up here.
Healthcare stocks were some of the top gainers early on. Britain’s GSK (GSK.L), opens new tab rose 3.3% after the drugmaker said Emma Walmsley will step down as CEO and will be replaced by insider Luke Miels in January.
UK’s AstraZeneca (AZN.L), opens new tab added 1.3% after the drugmaker said it would remain listed and headquartered in London, and would now directly list its shares on the New York Stock Exchange instead of the current depository shares.
Technology (.SX8P), opens new tab shares advanced 0.6%, with chipmakers ASMI (ASMI.AS), opens new tab and BE Semiconductor (BESI.AS), opens new tab up over 1% each.
Industrial goods and services (.SXNP), opens new tab was also among the top moving sub-sectors, gaining 0.4%.
U.S. President Donald Trump will meet with top Democratic and Republican leaders in Congress later on Monday to discuss extending government funding. Without a deal, a shutdown would begin on Wednesday.
A key reading of the September non-farm payrolls report in the U.S. is due later this week.
Reporting by Shashwat Chauhan in Bengaluru and Amir Orusov in Gdansk; Editing by Janane Venkatraman